| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 22.32B | 19.38B | 15.54B | 17.84B | 13.33B | 11.06B |
| Gross Profit | 9.07B | 7.69B | 5.17B | 3.81B | 60.00M | 2.50B |
| EBITDA | 6.63B | 7.19B | 4.62B | 1.29B | 852.00M | 3.16B |
| Net Income | 2.39B | 2.66B | 1.49B | -1.23B | -1.27B | 636.00M |
Balance Sheet | ||||||
| Total Assets | 38.15B | 37.77B | 32.97B | 32.79B | 29.68B | 25.21B |
| Cash, Cash Equivalents and Short-Term Investments | 458.00M | 1.19B | 3.48B | 455.00M | 1.32B | 406.00M |
| Total Debt | 18.05B | 17.36B | 14.68B | 13.34B | 11.01B | 9.88B |
| Total Liabilities | 33.31B | 32.19B | 27.64B | 27.87B | 21.39B | 16.85B |
| Stockholders Equity | 4.82B | 5.57B | 5.31B | 4.90B | 8.29B | 8.37B |
Cash Flow | ||||||
| Free Cash Flow | 3.11B | 2.48B | 3.78B | -816.00M | -1.24B | 2.08B |
| Operating Cash Flow | 4.23B | 4.56B | 5.45B | 485.00M | -206.00M | 3.34B |
| Investing Cash Flow | -2.75B | -5.28B | -2.15B | -1.24B | -1.15B | -1.57B |
| Financing Cash Flow | -2.64B | -1.60B | -294.00M | -80.00M | 2.27B | -1.80B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | $52.65B | 21.31 | 9.29% | 4.40% | 7.60% | 55.99% | |
72 Outperform | $73.93B | 19.08 | 8.31% | 4.05% | -6.02% | 7.24% | |
71 Outperform | $60.22B | 22.35 | 8.87% | 2.80% | 0.46% | -11.77% | |
70 Outperform | $71.44B | 33.45 | 45.85% | 0.43% | 46.90% | 388.66% | |
69 Neutral | $62.46B | 17.11 | 13.03% | 3.17% | 5.84% | 36.33% | |
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% | |
58 Neutral | $32.87B | 71.91 | 17.66% | 1.01% | 2.09% | -74.13% |